Aspen Pharmacare Holdings Ltd banner
A

Aspen Pharmacare Holdings Ltd
SWB:LDZA

Watchlist Manager
Aspen Pharmacare Holdings Ltd
SWB:LDZA
Watchlist
Price: 6.7 EUR 2.29%
Market Cap: €3B

Wall St Price Targets

LDZA Price Targets Summary
Aspen Pharmacare Holdings Ltd

Wall Street analysts forecast LDZA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for LDZA is 7.96 EUR with a low forecast of 7.17 EUR and a high forecast of 9.31 EUR.

Lowest Forecast
Price Target
7.17 EUR
7% Upside
Average Forecast
Price Target
7.96 EUR
19% Upside
Highest Forecast
Price Target
9.31 EUR
39% Upside
Aspen Pharmacare Holdings Ltd Competitors:
Price Targets
SITOWS
Sitowise Group Oyj
8% Upside

Revenue
Forecast

8% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
8% / Year
Past Growth
1% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 1%.

Operating Income
Forecast

5% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss
5% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 4%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-10%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is LDZA's stock price target?
Price Target
7.96 EUR

According to Wall Street analysts, the average 1-year price target for LDZA is 7.96 EUR with a low forecast of 7.17 EUR and a high forecast of 9.31 EUR.

What is the Revenue forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
1%

Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is 1%.

What is the Operating Income forecast for Aspen Pharmacare Holdings Ltd?
Projected CAGR
4%

Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 4%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett